4.7 Article

Folic acid handling by the human gut: implications for food fortification and supplementation

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 100, 期 2, 页码 593-599

出版社

OXFORD UNIV PRESS
DOI: 10.3945/ajcn.113.080507

关键词

-

资金

  1. UK Biotechnology and Biological Sciences Research Council [BB/F014104/1, BB1F014457/1]
  2. Biotechnology and Biological Sciences Research Council [BB/F012594/1, BBS/E/F/00044435, BB/F014457/1, BB/F014104/1] Funding Source: researchfish
  3. National Institute for Health Research [IS-BRC-0211-10046, NF-SI-0513-10091] Funding Source: researchfish
  4. NIHR Newcastle Biomedical Research Centre [BH141402, BH137357, BH134330, BH121729] Funding Source: researchfish
  5. BBSRC [BBS/E/F/00044435, BB/F014457/1, BB/F012594/1] Funding Source: UKRI

向作者/读者索取更多资源

Background: Current thinking, which is based mainly on rodent studies, is that physiologic doses of folic acid (pterylmonoglutamic acid), such as dietary vitamin folates, are biotransformed in the intestinal mucosa and transferred to the portal vein as the natural circulating plasma folate, 5-methyltetrahydrofolic acid (5-MTHF) before entering the liver and the wider systemic blood supply. Objective: We tested the assumption that, in humans, folic acid is biotransformed (reduced and methylated) to 5-MTHF in the intestinal mucosa. Design: We conducted a crossover study in which we sampled portal and peripheral veins for labeled folate concentrations after oral ingestion with physiologic doses of stable-isotope labeled folic acid or the reduced folate 5-formyltetrahydrofolic acid (5Formy1THF) in 6 subjects with a transjugular intrahepatic porto systemic shunt (TIPSS) in situ. The TIPSS allowed blood samples to be taken from the portal vein. Results: Fifteen minutes after a dose of folic acid, 80 12% of labeled folate in the hepatic portal vein was unmodified folic acid. In contrast, after a dose of labeled 5-Formy1THF, only 4 18% of labeled folate in the portal vein was unmodified 5-Formy1THF, and the rest had been converted to 5-MTHF after 15 min (postdose). Conclusions: The human gut appears to have a very efficient capacity to convert reduced dietary folates to 5-MTHF but limited ability to reduce folic acid. Therefore, large amounts of unmodified folic acid in the portal vein are probably attributable to an extremely limited mucosal cell dihydrofolate reductase (DHFR) capacity that is necessary to produce tetrahydrofolic acid before sequential methylation to 5-MTHF. This process would suggest that humans are reliant on the liver for folic acid reduction even though it has a low and highly variable DIAFR activity. Therefore, chronic liver exposure to folic acid in humans may induce saturation, which would possibly explain reports of systemic circulation of unmetabolized folic acid.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据